| Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 52.37 mm | 52.37 mm | 52.37 mm | 52.37 mm | 52.37 mm | 52.37 mm |
| Cash burn (monthly) | (no burn) | 2.19 mm | 1.67 mm | 5.64 mm | 7.15 mm | 7.34 mm |
| Cash used (since last report) | n/a | 50.57 mm | 38.49 mm | 130.10 mm | 164.86 mm | 169.42 mm |
| Cash remaining | n/a | 1.80 mm | 13.88 mm | -77.73 mm | -112.49 mm | -117.05 mm |
| Runway (months of cash) | n/a | 0.8 | 8.3 | -13.8 | -15.7 | -15.9 |
| 13F holders | Current |
|---|---|
| Total holders | 1 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 14.95 mm |
| Total shares | 15.33 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Hanmi Pharmaceutical | 15.33 mm | $14.95 mm |
